Does the media favor GH or CELC?

In the previous week, Celcuity had 16 more articles in the media than Guardant Health. MarketBeat recorded 33 mentions for Celcuity and 17 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.45 beat Celcuity's score of -0.09 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 6 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Celcuity 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 7 Very Negative mention(s) Neutral

Does the media refer more to BTSG or CELC?

In the previous week, Celcuity had 15 more articles in the media than BrightSpring Health Services. MarketBeat recorded 33 mentions for Celcuity and 18 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.73 beat Celcuity's score of -0.09 indicating that BrightSpring Health Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 7 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 7 Very Negative mention(s) Neutral

Does the media favor FMS or CELC?

In the previous week, Celcuity had 31 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 33 mentions for Celcuity and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.71 beat Celcuity's score of -0.09 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 7 Very Negative mention(s) Neutral

Does the media refer more to CELC or HIMS?

In the previous week, Celcuity had 17 more articles in the media than Hims & Hers Health. MarketBeat recorded 33 mentions for Celcuity and 16 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.92 beat Celcuity's score of -0.09 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 7 Very Negative mention(s) Neutral Hims & Hers Health 10 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, CELC or PACS?

PACS Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celcuity N/A N/A -$177.04M -$3.90 N/A PACS Group $5.29B 1.05 $191.54M $1.56 22.54

Is CELC or PACS more profitable?

PACS Group has a net margin of 4.49% compared to Celcuity's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Celcuity N/A -244.61% -50.22% PACS Group 4.49% 26.47% 4.36%

Does the media favor CELC or PACS?

In the previous week, Celcuity had 32 more articles in the media than PACS Group. MarketBeat recorded 33 mentions for Celcuity and 1 mentions for PACS Group. Celcuity's average media sentiment score of -0.09 beat PACS Group's score of -0.35 indicating that Celcuity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 7 Very Negative mention(s) Neutral PACS Group 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Celcuity (CELC) Competitors

$92.08 +4.65 (+5.32%)

As of 01:32 PM Eastern

Compare

CELC vs. GH, BTSG, FMS, HIMS, and PACS

Should you buy Celcuity stock or one of its competitors? MarketBeat compares Celcuity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Celcuity include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Celcuity compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

Guardant Health has a beta of 1.61, meaning that its stock price is 61% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.1, meaning that its stock price is 90% less volatile than the broader market.

Celcuity has a net margin of 0.00% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Celcuity	N/A	-244.61%	-50.22%

Guardant Health currently has a consensus target price of $139.80, suggesting a potential upside of 11.37%. Celcuity has a consensus target price of $152.09, suggesting a potential upside of 65.17%. Given Celcuity's higher possible upside, analysts clearly believe Celcuity is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	2.95
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Comparatively, 13.3% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Celcuity had 16 more articles in the media than Guardant Health. MarketBeat recorded 33 mentions for Celcuity and 17 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.45 beat Celcuity's score of -0.09 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	6 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Celcuity	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	7 Very Negative mention(s)	Neutral

Celcuity has lower revenue, but higher earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	16.95	-$416.28M	-$3.39	N/A
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

Summary

Guardant Health beats Celcuity on 10 of the 16 factors compared between the two stocks.

How does Celcuity compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

In the previous week, Celcuity had 15 more articles in the media than BrightSpring Health Services. MarketBeat recorded 33 mentions for Celcuity and 18 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.73 beat Celcuity's score of -0.09 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	7 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	7 Very Negative mention(s)	Neutral

BrightSpring Health Services has a beta of 1.87, meaning that its share price is 87% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.1, meaning that its share price is 90% less volatile than the broader market.

63.3% of Celcuity shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Comparatively, 13.3% of Celcuity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

BrightSpring Health Services currently has a consensus price target of $58.53, indicating a potential downside of 3.11%. Celcuity has a consensus price target of $152.09, indicating a potential upside of 65.17%. Given Celcuity's higher possible upside, analysts clearly believe Celcuity is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	3.11
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

BrightSpring Health Services has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$13.65B	0.87	$190.67M	$1.41	42.85
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

BrightSpring Health Services has a net margin of 2.27% compared to Celcuity's net margin of 0.00%. BrightSpring Health Services' return on equity of 14.63% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
Celcuity	N/A	-244.61%	-50.22%

Summary

BrightSpring Health Services beats Celcuity on 12 of the 16 factors compared between the two stocks.

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

In the previous week, Celcuity had 31 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 33 mentions for Celcuity and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.71 beat Celcuity's score of -0.09 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	7 Very Negative mention(s)	Neutral

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 13.3% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, Celcuity has a beta of 0.1, indicating that its share price is 90% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA currently has a consensus target price of $28.00, indicating a potential upside of 25.59%. Celcuity has a consensus target price of $152.09, indicating a potential upside of 65.17%. Given Celcuity's stronger consensus rating and higher probable upside, analysts plainly believe Celcuity is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Celcuity's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%
Celcuity	N/A	-244.61%	-50.22%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.90	11.73
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

Summary

Fresenius Medical Care AG & Co. KGaA beats Celcuity on 9 of the 15 factors compared between the two stocks.

How does Celcuity compare to Hims & Hers Health?

Celcuity (NASDAQ:CELC) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

63.3% of Celcuity shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 13.3% of Celcuity shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Celcuity has a beta of 0.1, meaning that its share price is 90% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, meaning that its share price is 137% more volatile than the broader market.

Hims & Hers Health has higher revenue and earnings than Celcuity. Hims & Hers Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Hims & Hers Health	$2.35B	2.71	$128.37M	-$0.09	N/A

In the previous week, Celcuity had 17 more articles in the media than Hims & Hers Health. MarketBeat recorded 33 mentions for Celcuity and 16 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.92 beat Celcuity's score of -0.09 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	7 Very Negative mention(s)	Neutral
Hims & Hers Health	10 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Celcuity has a net margin of 0.00% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Hims & Hers Health	-0.56%	6.10%	1.52%

Celcuity presently has a consensus price target of $152.09, suggesting a potential upside of 65.17%. Hims & Hers Health has a consensus price target of $28.70, suggesting a potential upside of 4.55%. Given Celcuity's stronger consensus rating and higher probable upside, research analysts clearly believe Celcuity is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

Summary

Hims & Hers Health beats Celcuity on 8 of the 15 factors compared between the two stocks.

How does Celcuity compare to PACS Group?

Celcuity (NASDAQ:CELC) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

Celcuity presently has a consensus price target of $152.09, suggesting a potential upside of 65.17%. PACS Group has a consensus price target of $48.00, suggesting a potential upside of 36.50%. Given Celcuity's stronger consensus rating and higher probable upside, equities analysts clearly believe Celcuity is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

PACS Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
PACS Group	$5.29B	1.05	$191.54M	$1.56	22.54

In the previous week, Celcuity had 32 more articles in the media than PACS Group. MarketBeat recorded 33 mentions for Celcuity and 1 mentions for PACS Group. Celcuity's average media sentiment score of -0.09 beat PACS Group's score of -0.35 indicating that Celcuity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	7 Very Negative mention(s)	Neutral
PACS Group	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

63.3% of Celcuity shares are held by institutional investors. 13.3% of Celcuity shares are held by insiders. Comparatively, 70.1% of PACS Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

PACS Group has a net margin of 4.49% compared to Celcuity's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
PACS Group	4.49%	26.47%	4.36%

Summary

PACS Group beats Celcuity on 8 of the 14 factors compared between the two stocks.

Get Celcuity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CELC vs. The Competition

Export

Metric	Celcuity	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.47B	$3.29B	$6.44B	$11.66B
Dividend Yield	N/A	2.31%	2.67%	5.58%
P/E Ratio	-23.53	18.96	23.83	23.35
Price / Sales	N/A	300.06	529.24	114.09
Price / Cash	N/A	51.45	26.99	37.25
Price / Book	42.43	7.99	10.46	6.62
Net Income	-$177.04M	$23.89M	$3.56B	$337.25M
7 Day Performance	0.72%	-4.56%	-1.94%	-3.41%
1 Month Performance	-29.74%	0.47%	0.29%	0.36%
1 Year Performance	613.24%	34.47%	19.72%	22.27%

Celcuity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CELC Celcuity	3.0639 of 5 stars	$92.08 +5.3%	$152.09 +65.2%	+570.0%	$4.47B	N/A	N/A	40
GH Guardant Health	2.4226 of 5 stars	$129.53 -0.1%	$136.37 +5.3%	+159.9%	$17.20B	$1.08B	N/A	2,506	Analyst Forecast Insider Trade
BTSG BrightSpring Health Services	4.0116 of 5 stars	$60.25 -2.3%	$57.64 -4.3%	+145.6%	$11.96B	$12.91B	42.56	23,500	Positive News Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.8521 of 5 stars	$20.97 -2.8%	$28.00 +33.5%	-23.6%	$11.65B	$19.36B	11.03	1,488
HIMS Hims & Hers Health	3.0925 of 5 stars	$27.53 +5.3%	$28.70 +4.2%	-52.0%	$6.43B	$2.37B	N/A	2,442	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CELC) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Celcuity (CELC) Competitors

CELC vs. GH, BTSG, FMS, HIMS, and PACS

How does Celcuity compare to Guardant Health?

Summary

How does Celcuity compare to BrightSpring Health Services?

Summary

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Celcuity compare to Hims & Hers Health?

Summary

How does Celcuity compare to PACS Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CELC vs. The Competition

Celcuity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Celcuity (CELC) Competitors

CELC vs. GH, BTSG, FMS, HIMS, and PACS

How does Celcuity compare to Guardant Health?

Which has more risk & volatility, GH or CELC?

Is GH or CELC more profitable?

Do analysts recommend GH or CELC?

Do institutionals and insiders have more ownership in GH or CELC?

Does the media favor GH or CELC?

Which has stronger earnings and valuation, GH or CELC?

Summary

How does Celcuity compare to BrightSpring Health Services?

Does the media refer more to BTSG or CELC?

Which has more risk and volatility, BTSG or CELC?

Do institutionals & insiders believe in BTSG or CELC?

Do analysts prefer BTSG or CELC?

Which has higher earnings and valuation, BTSG or CELC?

Is BTSG or CELC more profitable?

Summary

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Does the media favor FMS or CELC?

Do institutionals & insiders hold more shares of FMS or CELC?

Which has more volatility and risk, FMS or CELC?

Do analysts rate FMS or CELC?

Is FMS or CELC more profitable?

Which has preferable earnings and valuation, FMS or CELC?

Summary

How does Celcuity compare to Hims & Hers Health?

Do institutionals and insiders have more ownership in CELC or HIMS?

Which has more volatility and risk, CELC or HIMS?

Which has higher earnings & valuation, CELC or HIMS?

Does the media refer more to CELC or HIMS?

Is CELC or HIMS more profitable?

Do analysts prefer CELC or HIMS?

Summary

How does Celcuity compare to PACS Group?

Do analysts prefer CELC or PACS?

Which has stronger earnings and valuation, CELC or PACS?

Does the media favor CELC or PACS?

Do insiders & institutionals have more ownership in CELC or PACS?

Is CELC or PACS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CELC vs. The Competition

Celcuity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools